### Comment:
Basically, if a company is doing a gene therapy product, invest in it. 
  
  
 2019 is the year of gene therapy.  
  
  
 ...except Gilead because Yescarta is getting fucked by Novartis Kymriah.

### REPLY:
Examples? CRSP or whatever?

### END.